{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pfam:PF00064",
      "entity_text" : "neuraminidase",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:78000",
      "entity_text" : "Tamiflu",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "XREF_BIBR Recent years have seen the development of effective antiviral agents such as the drugs oseltamivir (Tamiflu) and zanamivir (Relenza) which inhibit viral neuraminidase (in contrast to anti-influenza vaccines, which target viral haemagglutinin).",
  "reading_complete" : "2020-07-28T10:13:16Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T09:52:04Z",
  "trigger" : "inhibit",
  "evidence" : [ "Tamiflu) and zanamivir (Relenza) which inhibit viral neuraminidase" ],
  "pmc_id" : "7182120",
  "score" : 0
}